Survival outcomes of parotid carcinomas treated with surgery and adjuvant radiation therapy

Maliha Kazi; Laura Warner; Amar Rajgor; Shahid Iqbal

doi:10.18203/issn.2454-5929.ijohns20260657

Authors

Maliha Kazi Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK https://orcid.org/0009-0006-7711-6185
Laura Warner Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK
Amar Rajgor Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK https://orcid.org/0000-0002-9323-3107
Shahid Iqbal Department of Clinical Oncology, Freeman Hospital, Newcastle Upon Tyne, UK https://orcid.org/0000-0002-6161-9128

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20260657

Keywords:

Parotid carcinoma, Surgery, Radiotherapy, Surgical margins, Survival, Recurrence

Abstract

Background: Parotid cancers are a diverse histological group of cancers involving the parotid gland with varying effects of prognostic factors on treatment outcomes. The effect of adjuvant radiotherapy on the outcome in parotid cancers has always been debated in the past. The objective of current study was to measure the effect of prognostic factors and the survival outcomes of patients with primary parotid cancers treated with surgery and adjuvant radiotherapy.

Methods: From January 2010 to December 2023, a total of 61 patients treated at Freeman Hospital, were included in the analysis. Data was collected and stratified according to age, gender, tumour staging, surgical margins, lymphovascular invasion (LVI), peri-neural invasion (PNI), extra nodal extension (ENE) and recurrence rate. All patients treated with surgery and adjuvant radiotherapy were included in the study. Patients with incomplete data, distant metastasis or those lost to follow up were excluded. The OS, DSS and RFS rates based on surgical margins, LVI, PNI and ENE were calculated.

Results: The 5-year OS, DSS and RFS were 72.6%, 79.6% and 77.7%, respectively. Positive surgical margins did not influence the survival outcome in comparison to close or clear margins. Lower survival rates were noted for patients with ENE, although not reaching statistical significance.

Conclusion: Though retrospective in nature, our study provides valuable information that close or involved surgical margins do not adversely affect the outcome for parotid cancers treated with surgery and adjuvant radiotherapy and that surgical re-resection might not be indicated in this patient population.

Metrics

Metrics Loading ...

References

Huyett P, Duvvuri U, Ferris R, Johnson J, Schaitkin B, Kim S. Perineural Invasion in Parotid Gland Malignancies. Otolaryngol Head Neck Surg. 2018;158(6):1035–104. DOI: https://doi.org/10.1177/0194599817751888

Carrillo JF, Vazquez R, Ramirez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Onate-Ocana LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer. 2007;109(10):2043-51. DOI: https://doi.org/10.1002/cncr.22647

Cederblad L, Johansson S, Enblad G, Engstrom M, Blomquist E. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival. Acta Oncol. 2009;48(4):549-55. DOI: https://doi.org/10.1080/02841860802680419

Loh KS, Barker E, Bruch G, O'Sullivan B, Brown DH, Goldstein DP, et al. Prognostic factors in malignancy of the minor salivary glands. Head Neck. 2009;31(1):58-63. DOI: https://doi.org/10.1002/hed.20924

Therkildsen MH, Christensen M, Andersen LJ, Schiodt T and Hansen HS. Salivary gland carcinomas–prognostic factors. Acta Oncol. 1998;37(7):701-13. DOI: https://doi.org/10.1080/028418698430089

Lin CC, Tsai MH, Huang CC, Hua CH, Tseng HC, Huang ST. Parotid tumors: A 10-year experience. Am J Otolaryngol Head Neck Med Surg. 2008;29(2):94-100. DOI: https://doi.org/10.1016/j.amjoto.2007.03.002

Takahama Junior A, Almeida OP, Kowalski LP. Parotid neoplasms: Analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol. 2009;75(4):497-501. DOI: https://doi.org/10.1590/S1808-86942009000400005

Mag A, Cotulbea S, Lupescu S, Stefanescu H, Doros C, Draganescu V, et al. Parotid gland tumors. J Exp Med Surg Res 2010;17:259-63.

Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: A clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835-45. DOI: https://doi.org/10.1097/00000478-200107000-00001

Ali S, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol. 2014;21(9):3042-8. DOI: https://doi.org/10.1245/s10434-014-3681-y

Dahan LS, Giorgi R, Garrel R, de Gabory LLT, Costes-Martineau V, Herman P, et al. Management of cN0 low-grade mucoepidermoid carcinomas of salivary glands: Prospective multicentre study of 152 cases of the French Network of Rare Head and Neck Tumors (REFCOR). Clinical Otolaryngol. 2020;45(6):926-31. DOI: https://doi.org/10.1111/coa.13600

Müller S, Boy SC, Day TA, Magliocca KR, Richardson MS, Sloan P, et al. Data set for the reporting of oral cavity carcinomas: Explanations and recommendations of the guidelines from the International Collaboration of Cancer Reporting. Arch Pathol Lab Med. 2019;143(4):439-46. DOI: https://doi.org/10.5858/arpa.2018-0411-SA

Morse E, Fujiwara RJT, Judson B, Prasad ML, Mehra S. Positive surgical margins in parotid malignancies: institutional variation and survival association: positive surgical margins in parotid cancer. Laryngoscope. 2019;129(1):129-37. DOI: https://doi.org/10.1002/lary.27221

Pantvaidya GH, Vaidya AD, Metgudmath R, Kane SV, D’Cruz AK. Minor salivary gland tumors of the sinonasal region: results of a retrospective analysis with review of literature. 2012;34(12):1704-10. DOI: https://doi.org/10.1002/hed.21988

Gutschenritter T, Machiorlatti M, Vesely S, Ahmad B, Razaq W, Razaq M. Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution’s 12-year Experience. Anticancer Research 2017;37(9):5019-25. DOI: https://doi.org/10.21873/anticanres.11916

Morand GB, Eskander A, Fu R, de Almeida J, Goldstein D, Noroozi H, et al. The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: a study of the Canadian head and neck collaborative research initiative. Cancer. 2023;129(20):3263-74. DOI: https://doi.org/10.1002/cncr.34932

Lin YC, Chen KC, Lin CH, Kuo KT, Ko KT, Hong RL. Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas. Int J Oral Maxillofac Surg. 2012;41:354–60. DOI: https://doi.org/10.1016/j.ijom.2011.12.022

Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, et al. A predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol Head Neck Surg. 2013;139(7):698-705.

Erovic BM, Shah MD, Bruch G, Johnston M, Kim J, O’Sullivan B, et al. Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis. J Otolaryngol-Head Neck Sur. 2015;44:43. DOI: https://doi.org/10.1186/s40463-015-0105-3

Ouyang, Liang, Li-zhong, Ke Z, Weng D, Yang W, et al. Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern China. a 25-year retrospective study. Medicine. 2017;96(5):5964. DOI: https://doi.org/10.1097/MD.0000000000005964

Katabi N, Ghossein R, Ali S, Dogan S, Klimstra D, Ganly I. Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading. Histopathology. 2014;65(6):793-804. DOI: https://doi.org/10.1111/his.12488

Kazemian E, Solinski M, Adams W, Moore M, Thorpe EJ. The role of perineural invasion in parotid Malignancy outcomes: A systematic review and meta-analysis. Oral Oncol. 2022;130:105937. DOI: https://doi.org/10.1016/j.oraloncology.2022.105937

Hsieh CE, Hung CY, Lin CY, Chen JS, Chang KP, Aithala SP, et al. High metastatic node number, not extranodal extension, as a node-related prognosticator in surgically treated patients with nodal metastatic salivary gland carcinoma. Head Neck. 2019;41(6):1572-82. DOI: https://doi.org/10.1002/hed.25603

Lee DH, Yoona TM, Lee JK, Lim SG. Clinicopathologic factors associated with recurrence in parotid carcinoma. Braz J Otorhinolaryngol. 2018;84(6):691-6. DOI: https://doi.org/10.1016/j.bjorl.2017.08.003

Godballe C, Schultz JH, Krogdahl A, Møller-Grøntved A, Johansen J. Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series. Laryngoscope. 2003;113(8):1411-7. DOI: https://doi.org/10.1097/00005537-200308000-00028

Stodulski D, Mikaszewski B, Stankiewicz C. Are all prognostic factors in parotid gland carcinoma well recognized. Eur Arch Otorhinolaryngol 2012;269(3):1019-25. DOI: https://doi.org/10.1007/s00405-011-1716-6